DexCom ROE 2010-2024 | DXCM

Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
DexCom ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.64B $2.25B 29.43%
2023-12-31 $0.54B $2.07B 25.01%
2023-09-30 $0.38B $2.27B 17.31%
2023-06-30 $0.36B $2.10B 17.27%
2023-03-31 $0.29B $2.23B 13.88%
2022-12-31 $0.34B $2.13B 16.23%
2022-09-30 $0.24B $1.83B 11.74%
2022-06-30 $0.23B $2.26B 10.67%
2022-03-31 $0.26B $2.19B 12.29%
2021-12-31 $0.22B $2.04B 10.74%
2021-09-30 $0.63B $2.14B 32.20%
2021-06-30 $0.62B $2.00B 34.21%
2021-03-31 $0.59B $1.90B 35.61%
2020-12-31 $0.55B $1.83B 39.11%
2020-09-30 $0.23B $1.50B 19.78%
2020-06-30 $0.21B $1.35B 20.83%
2020-03-31 $0.15B $0.94B 18.10%
2019-12-31 $0.10B $0.88B 13.45%
2019-09-30 $-0.17B $0.76B -24.71%
2019-06-30 $-0.17B $0.69B -26.49%
2019-03-31 $-0.13B $0.67B -21.89%
2018-12-31 $-0.13B $0.66B -23.86%
2018-09-30 $0.04B $0.56B 9.34%
2018-06-30 $-0.01B $0.48B -1.17%
2018-03-31 $-0.03B $0.42B -8.11%
2017-12-31 $-0.05B $0.42B -13.94%
2017-09-30 $-0.05B $0.38B -14.77%
2017-06-30 $-0.07B $0.35B -22.07%
2017-03-31 $-0.09B $0.28B -32.90%
2016-12-31 $-0.07B $0.28B -25.42%
2016-09-30 $-0.06B $0.26B -23.33%
2016-06-30 $-0.08B $0.25B -35.91%
2016-03-31 $-0.06B $0.23B -31.37%
2015-12-31 $-0.06B $0.22B -31.61%
2015-09-30 $-0.06B $0.19B -36.14%
2015-06-30 $-0.02B $0.17B -14.61%
2015-03-31 $-0.02B $0.15B -18.25%
2014-12-31 $-0.02B $0.14B -20.67%
2014-09-30 $-0.03B $0.12B -27.76%
2014-06-30 $-0.03B $0.10B -32.09%
2014-03-31 $-0.03B $0.09B -39.88%
2013-12-31 $-0.03B $0.08B -39.34%
2013-09-30 $-0.04B $0.08B -46.98%
2013-06-30 $-0.05B $0.07B -60.73%
2013-03-31 $-0.05B $0.07B -63.35%
2012-12-31 $-0.05B $0.08B -62.07%
2012-09-30 $-0.06B $0.08B -61.70%
2012-06-30 $-0.05B $0.09B -52.81%
2012-03-31 $-0.05B $0.10B -41.82%
2011-12-31 $-0.04B $0.11B -44.78%
2011-09-30 $-0.04B $0.11B -48.14%
2011-06-30 $-0.04B $0.12B -61.99%
2011-03-31 $-0.05B $0.05B -98.95%
2010-12-31 $-0.06B $0.06B -119.57%
2010-09-30 $-0.06B $0.04B -217.14%
2010-06-30 $-0.06B $0.04B -380.33%
2010-03-31 $-0.06B $0.05B -1109.09%
2009-12-31 $-0.05B $-0.02B 2160.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $51.973B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
Edwards Lifesciences (EW) United States $54.101B 35.21
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Masimo (MASI) United States $6.723B 38.73
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00